chcr logo

Measuring Chemotoxicity with IVR


This study examines the agreement between prospective and retrospective reporting of toxicities and health care service use (e.g., unscheduled office visit, emergency department visit, hospitalization) by patients with cancer treated with systemic chemotherapy. This information will provide the Cancer Center with rich patient outcomes data to inform quality improvement efforts.


Aim 1. Assess the agreement among prospective, retrospective, and medical record reporting of chemotherapy toxicities and health care service use.

Aim 2.
Investigate the relationship between toxicity and health care service use.


150 patients with invasive breast, non-small cell lung, colorectal, and head and neck cancers who are scheduled to initiate a new chemotherapy regimen at the University of Michigan Comprehensive Cancer Center.

Related Projects